Categories: News

TE Connectivity completes acquisition of Richards Manufacturing

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GALWAY, Ireland, April 1, 2025 /PRNewswire/ — TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, completed the previously announced acquisition of Richards Manufacturing Co.

Richards is a North American leader in utility grid products, including underground distribution equipment. The acquisition will enable TE to capitalize on the region’s grid replacement and upgrade cycle, strengthening its leadership in serving utilities and other energy customers around the world.

The acquired business will continue to be run by the Richards management team, ensuring business continuity as it integrates with TE.

About TE Connectivity
TE Connectivity plc (NYSE: TEL) is a global industrial technology leader creating a safer, sustainable, productive, and connected future. Our broad range of connectivity and sensor solutions enable the distribution of power, signal and data to advance next-generation transportation, energy networks, automated factories, data centers, medical technology and more. With more than 85,000 employees, including 9,000 engineers, working alongside customers in approximately 130 countries, TE ensures that EVERY CONNECTION COUNTS. Learn more at www.te.com and on LinkedIn, Facebook, WeChat, Instagram and X (formerly Twitter).

View original content to download multimedia:https://www.prnewswire.com/news-releases/te-connectivity-completes-acquisition-of-richards-manufacturing-302417507.html

SOURCE TE Connectivity plc

Staff

Recent Posts

Morgan AH Medical Unveils Patented Rolling Expandable Bathtub at Abilities Expo Chicago – Hailed as a “Game Changer” for Accessible Bathing

Chicago, Illinois--(Newsfile Corp. - July 3, 2025) - Morgan AH Medical made headlines at this…

24 minutes ago

Hemostemix Announces its 10th Publication: A Molecular Strategy for the Treatment of Heart Failure: Response to BioCardia’s Cardiamp Heart Failure Trial

Calgary, Alberta--(Newsfile Corp. - July 3, 2025) -  Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0)…

24 minutes ago

Apollo Biowellness, Inc. Re-Files Application with OTCMarkets.com

North Bergen, New Jersey--(Newsfile Corp. - July 3, 2025) - Apollo Biowellness, Inc. (OTC Pink:…

1 hour ago

AAMI Aligns With National Academy of Medicine AI Code of Conduct

AI Code of Conduct’s six core principles key to ensuring the safe and effective use…

2 hours ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Vancouver, Canada, July 03, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0)…

2 hours ago